SEC Form 4 · accession 0001562180-18-001152
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen Flynn
Officer — Sr VP & Chief Commercial Offic
Period of report
Feb 20, 2018
Accepted (ET)
Feb 22, 2018 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F1 | $89.64 | Feb 20, 2018 | A | 17,544 | A | Feb 20, 2019 | Feb 20, 2028 | Common Stock | 17,544 | 17,544 | D |
Explanation of responses
- F1This award vests in 4 equal annual installments beginning on 2/20/2019